News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
503,499 Results
Type
Article (29795)
Company Profile (370)
Press Release (473323)
Multimedia
Podcasts (111)
Webinars (16)
Section
Business (136019)
Career Advice (434)
Deals (24700)
Drug Delivery (90)
Drug Development (66784)
Employer Resources (67)
FDA (12374)
Job Trends (9990)
News (238869)
Policy (19311)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Standard (3)
Academia (1835)
Academic (1)
Accelerated approval (26)
Adcomms (20)
Allergies (129)
Alliances (37129)
ALS (161)
Alzheimer's disease (1519)
Antibody-drug conjugate (ADC) (324)
Approvals (12707)
Artificial intelligence (476)
Autoimmune disease (154)
Automation (35)
Bankruptcy (177)
Best Places to Work (8466)
BIOSECURE Act (15)
Biosimilars (169)
Biotechnology (263)
Bladder cancer (143)
Brain cancer (55)
Breast cancer (586)
Cancer (4491)
Cardiovascular disease (398)
Career advice (394)
Career pathing (17)
CAR-T (280)
CDC (9)
Cell therapy (741)
Cervical cancer (30)
Clinical research (57841)
Collaboration (1717)
Company closure (2)
Compensation (878)
Complete response letters (56)
COVID-19 (2093)
CRISPR (94)
C-suite (826)
Cystic fibrosis (132)
Data (5874)
Denatured (40)
Depression (126)
Diabetes (454)
Diagnostics (5145)
Digital health (40)
Diversity (8)
Diversity, equity & inclusion (19)
Drug discovery (249)
Drug pricing (91)
Drug shortages (16)
Duchenne muscular dystrophy (235)
Earnings (53695)
Editorial (37)
Employer branding (12)
Employer resources (61)
Events (86399)
Executive appointments (918)
FDA (15185)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (24)
Funding (1358)
Gene editing (201)
Generative AI (41)
Gene therapy (598)
GLP-1 (850)
Government (2559)
Grass and pollen (8)
Guidances (315)
Healthcare (12834)
HIV (54)
Huntington's disease (45)
IgA nephropathy (88)
Immunology and inflammation (230)
Immuno-oncology (56)
Indications (117)
Infectious disease (2317)
Inflammatory bowel disease (191)
Inflation Reduction Act (11)
Influenza (93)
Intellectual property (230)
Interviews (52)
IPO (12153)
IRA (24)
Job creations (1937)
Job search strategy (347)
JPM (54)
Kidney cancer (15)
Labor market (42)
Layoffs (378)
Leadership (17)
Legal (3257)
Liver cancer (77)
Longevity (16)
Lung cancer (606)
Lymphoma (360)
Machine learning (40)
Management (17)
Manufacturing (683)
MASH (162)
Medical device (9285)
Medtech (9317)
Mergers & acquisitions (13508)
Metabolic disorders (1132)
mRNA (149)
Multiple sclerosis (154)
NASH (17)
Neurodegenerative disease (311)
Neuropsychiatric disorders (81)
Neuroscience (2685)
Neurotech (1)
NextGen: Class of 2026 (3694)
Non-profit (2693)
Now hiring (44)
Obesity (511)
Opinion (186)
Ovarian cancer (155)
Pain (156)
Pancreatic cancer (214)
Parkinson's disease (271)
Partnered (28)
Patents (435)
Patient recruitment (467)
Peanut (54)
People (43916)
Pharmaceutical (66)
Pharmacy benefit managers (9)
Phase 1 (18452)
Phase 2 (25419)
Phase 3 (19156)
Pipeline (5076)
Policy (161)
Postmarket research (1831)
Preclinical (7642)
Press Release (60)
Prostate cancer (228)
Psychedelics (52)
Radiopharmaceuticals (278)
Rare diseases (833)
Real estate (3709)
Recruiting (28)
Regulatory (17317)
Reports (28)
Research institute (1905)
Resumes & cover letters (48)
Rett syndrome (27)
RNA editing (21)
RSV (53)
Schizophrenia (144)
Series A (237)
Series B (174)
Service/supplier (5)
Sickle cell disease (103)
Special edition (21)
Spinal muscular atrophy (145)
Sponsored (37)
Startups (2712)
State (1)
Stomach cancer (12)
Supply chain (85)
Tariffs (37)
The Weekly (70)
Vaccines (772)
Venture capital (80)
Weight loss (308)
Women's health (77)
Worklife (3)
Date
Today (176)
Last 7 days (627)
Last 30 days (2194)
Last 365 days (26337)
2026 (3717)
2025 (26547)
2024 (30147)
2023 (33607)
2022 (43710)
2021 (46640)
2020 (42593)
2019 (32186)
2018 (24094)
2017 (24507)
2016 (22908)
2015 (26833)
2014 (20021)
2013 (15812)
2012 (16606)
2011 (16263)
2010 (14959)
Location
Africa (455)
Alabama (74)
Alaska (4)
Arizona (161)
Arkansas (12)
Asia (32243)
Australia (5583)
California (9815)
Canada (2747)
China (1124)
Colorado (396)
Connecticut (385)
Delaware (322)
Europe (72851)
Florida (1357)
Georgia (328)
Hawaii (4)
Idaho (36)
Illinois (680)
India (69)
Indiana (463)
Iowa (15)
Japan (436)
Kansas (107)
Kentucky (21)
Louisiana (16)
Maine (41)
Maryland (1147)
Massachusetts (7538)
Michigan (302)
Minnesota (455)
Mississippi (4)
Missouri (105)
Montana (31)
Nebraska (14)
Nevada (92)
New Hampshire (65)
New Jersey (2745)
New Mexico (26)
New York (2573)
North Carolina (1244)
North Dakota (9)
Northern California (4805)
Ohio (274)
Oklahoma (19)
Oregon (33)
Pennsylvania (1973)
Puerto Rico (22)
Rhode Island (36)
South America (646)
South Carolina (24)
Southern California (3845)
Tennessee (120)
Texas (1364)
United States (34604)
Utah (201)
Virginia (222)
Washington D.C. (64)
Washington State (816)
West Virginia (2)
Wisconsin (96)
Wyoming (2)
503,499 Results for "global blood therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Circular Genomics Finalizes Exclusive IP Licenses with Leading Global Research Institutions to Advance circRNA Blood Test for Alzheimer’s Disease
February 11, 2026
·
3 min read
Press Releases
ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury
February 4, 2026
·
7 min read
Press Releases
LifeArc and Global Alzheimer’s Platform Foundation - Scientists test whether a finger prick blood test could be used to help diagnose Alzheimer’s disease before symptoms begin
January 19, 2026
·
6 min read
Weight loss
Novo’s Next-Gen Obesity Drug Beats Wegovy on Blood Sugar Control in Phase III
While CagriSema bested Novo Nordisk’s Wegovy on blood sugar control in a late-stage trial, the next-gen weight loss drug still has not met the pharma’s 25% weight loss goal.
February 3, 2026
·
2 min read
·
Tristan Manalac
Press Releases
AN2 Therapeutics to Participate in Fireside Chat at Leerink Global Healthcare Conference
February 17, 2026
·
1 min read
Press Releases
Akari Therapeutics to Present at the 2026 Biocom Global Partnering & Investor Conference
February 18, 2026
·
2 min read
Press Releases
Aprea Therapeutics Strengthens Global Patent Portfolio in DNA Damage Response (DDR) Cancer Therapeutics, Paving Way for Pipeline Growth
February 12, 2026
·
6 min read
Press Releases
Seamless Therapeutics Announces Global Research Collaboration with Lilly to Develop Programmable Recombinase-based Therapeutics for Hearing Loss
January 28, 2026
·
3 min read
Press Releases
Origami Therapeutics Announces Global Collaboration with Ipsen to Advance Protein Degrader Program
February 2, 2026
·
2 min read
Press Releases
Myosin Therapeutics Invited to Present at Biocom California’s Global Partnering & Investor Conference
January 30, 2026
·
3 min read
1 of 50,350
Next
